(104) demonstrated that ATO blocked the paracrine signaling of Ang-1 and Ang-2 by inhibiting p-Akt/Hif-1a and further suppressed angiogenesis of HCC after insufficient RFA. Here, AKT1 is linked to hepatocellular carcinoma.